Skip to main content
. 2024 May 30;25(7):2974–3007. doi: 10.1038/s44319-024-00164-z

Table 1.

Genetic association of rs111337717 and rs116858620 SNP in ATP2B1 gene with severe and asymptomatic cases.

rs111337717 Severe cases Asymptomatic cases P OR
Genotype N = 197 N = 379
 TT 165 (0.84) 345 (0.93)
 CT 31 (0.15) 24 (0.06)
 CC 1 (0.005) 1 (0.002) 0.0005a 2.3
Allele N.394 N-740
 T 361 (0.92) 714 (0.96)
 C 33 (0.08) 26 (0.03) 0.0004b 2.5
rs116858620 Severe cases Asymptomatic cases P OR
Genotype N = 199 N = 364
 TT 189 (0.95) 343 (0.94)
 CT 10 (0.05) 21 (0.06)
 CC 0 (0.0) 0 (0.0) 0.71 0.86
Allele N = 398 N = 728
 T 388 (0.97) 707 (0.97)
 C 10 (0.03) 21 (0.03) 0.71 0.86

The rs111337717 and rs116858620 SNPs in ATP2B1 gene were tested in a cohort of n.197 patients affected by severe COVID-19 and n.370 asymptomatic cases. The minor allele “C” of rs111337717 (NC_000012.12:g.89643729 T > C) with a frequency of 0.03% in our analyzed cohort; SNP [(CACATG(T/C)ACATTAT)] is significantly more frequent among severe COVID-19 cases when compared with asymptomatic individuals (P = 0.0004), thus suggesting rs111337717 SNP could be listed among the genetic risk factor for predisposition to sever COVID-19.

aArmitage trend test: Severe cases vs. Asymptomatic cases.

bFisher’s exact test: severe cases vs. Asymptomatic cases.